{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:37:07Z","timestamp":1788745027573,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.014","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T01:58:46Z","timestamp":1584410326000},"page":"3411-3421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunogenicity and safety of the RTS,S\/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Kwaku Poku","family":"Asante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ansong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-4203","authenticated-orcid":false,"given":"Seyram","family":"Kaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Nana Badu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Agyapong Darko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Boakye Yiadom Buabeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owusu","family":"Boahen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Maria Rettig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Agutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Benard Ekow Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw","family":"Ntiamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Japhet","family":"Adomako Anim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Adeniji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Agordo Dornudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Gvozdenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dosoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sambian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Owusu-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis","family":"Ato Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Prempeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Vandoolaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Owusu-Agyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsiri","family":"Agbenyega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.014_b0005","unstructured":"World Health Organization. World malaria report, http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/275867\/9789241565653-eng.pdf?ua=1; 2018 [accessed 13 August 2019]."},{"key":"10.1016\/j.vaccine.2020.03.014_b0010","unstructured":"World Health Organization. Malaria in children under five, http:\/\/www.who.int\/malaria\/areas\/high_risk_groups\/children\/en\/; 2018 [accessed 30 May 2018]."},{"key":"10.1016\/j.vaccine.2020.03.014_b0015","unstructured":"World Health Organization. Larval source management: a supplementary measure for malaria vector control. An operational manual, http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/85379\/9789241505604_eng.pdf;jsessionid=5D313FF934519E9FE9578359D9F9916A?sequence=1; 2013 [accessed 13 August 2019]."},{"key":"10.1016\/j.vaccine.2020.03.014_b0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen","year":"2010","journal-title":"Hum Vaccin."},{"key":"10.1016\/j.vaccine.2020.03.014_b0025","unstructured":"European Medicines Agency. Committee for medicinal products for human use. Assessment report - Mosquirix, https:\/\/www.ema.europa.eu\/en\/documents\/medicine-outside-eu\/mosquirix-public-assessment-report_en.pdf; 2015 [accessed 13 August 2019]."},{"key":"10.1016\/j.vaccine.2020.03.014_b0030","first-page":"33","article-title":"Malaria vaccine: WHO position paper-January 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.03.014_b0035","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/21645515.2018.1442996","article-title":"Immune response to the hepatitis B antigen in the RTS, S\/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial","volume":"14","author":"Valea","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.03.014_b0040","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa0807773","article-title":"Safety and immunogenicity of RTS, S\/AS02D malaria vaccine in infants","volume":"359","author":"Abdulla","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.014_b0045","doi-asserted-by":"crossref","first-page":"88ra56","DOI":"10.1126\/scitranslmed.3002461","article-title":"Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants","volume":"3","author":"Ota","year":"2011","journal-title":"Sci Transl Med"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2020.03.014_b0050","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1093\/cid\/civ603","article-title":"Immunogenicity of yellow fever vaccine coadministered with MenAfriVac in healthy infants in Ghana and Mali","volume":"61","author":"Roy Chowdhury","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.014_b0055","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/656190","article-title":"Evaluation of the safety and immunogenicity of the RTS, S\/AS01E malaria candidate vaccine when integrated in the expanded program of immunization","volume":"202","author":"Agnandji","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.014_b0060","unstructured":"Ministry of Health\/Ghana Health Service. Immunization programme comprehensive multi-year plan (2010\u20132014), http:\/\/www.nationalplanningcycles.org\/sites\/default\/files\/country_docs\/Ghana\/revised_cmyp_2010_-_2014.pdf; 2011 [accessed 13 August 2019]."},{"key":"10.1016\/j.vaccine.2020.03.014_b0065","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2214-109X(16)30075-4","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia","volume":"4","author":"Clarke","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.03.014_b0070","unstructured":"World Health Organization. Guideline: Vitamin A supplementation in infants and children 6\u201359 months of age, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44664\/9789241501767_eng.pdf;jsessionid=0FBD1354F93D1AE4F41A5128E08E175C?sequence=1; 2011 [accessed 13 August 2019]."},{"key":"10.1016\/j.vaccine.2020.03.014_b0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.03.014_b0080","first-page":"301","article-title":"Rubella vaccines: WHO position paper","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.03.014_b0085","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1473-3099(11)70100-1","article-title":"Safety and efficacy of the RTS, S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial","volume":"11","author":"Asante","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.014_b0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"10.1016\/j.vaccine.2020.03.014_b0095","first-page":"269","article-title":"Confidence intervals for the ratio of the parameters of two independent binomials","volume":"46","author":"Nurminen","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2020.03.014_b0100","doi-asserted-by":"crossref","unstructured":"RTS, S clinical trials partnership. First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children. N Engl J Med. 2011;365:1863\u201375. 10.1056\/NEJMoa1102287.","DOI":"10.1056\/NEJMoa1102287"},{"key":"10.1016\/j.vaccine.2020.03.014_b0105","doi-asserted-by":"crossref","unstructured":"RTS, S clinical trials partnership. Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11:e1001685. 10.1371\/journal.pmed.1001685.","DOI":"10.1371\/journal.pmed.1001685"},{"key":"10.1016\/j.vaccine.2020.03.014_b0110","doi-asserted-by":"crossref","unstructured":"RTS, S clinical trials partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31-45. 10.1016\/s0140-6736(15)60721-8.","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"10.1016\/j.vaccine.2020.03.014_b0115","unstructured":"Dolan S, Wallace A, Burnett E, Ehlman D, Sui W, Garon J, et al. Summary of evidence on the administration of multiple injectable vaccines in infants during a single visit: safety, immunogenicity, and vaccine administration practices. Prepared for the April 2015 SAGE Meeting. In: SAGE Yellow Book; Geneva, Switzerland: World Health Organization, 2015. p. 222\u201364."},{"key":"10.1016\/j.vaccine.2020.03.014_b0120","first-page":"1","article-title":"Safety profile of the RTS, S\/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa","author":"Guerra Mendoza","year":"2019","journal-title":"Hum Vaccines Immunotherapeutics."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:12Z","timestamp":1759401732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303583"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of the RTS,S\/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}